SCHEMBL5066196

SCHEMBL5066196

C=CCOCCCOC(=O)C=C.C=CCOCCOC(=O)C=C

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.64
ALDH1A1 P00352 4/20 0.64
TP53 P04637 3/20 0.64
HIF1A Q16665 3/20 0.64
HSD17B10 Q99714 1/20 0.64
CYP3A4 P08684 3/20 0.59
HPGD P15428 1/20 0.53
THRB P10828 2/20 0.49
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
HCAR2 Q8TDS4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958348 0.96 TSHR (0.63) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL11552072 0.92 TSHR (0.69) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL85965 0.92 TSHR (0.75) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL19678288 0.91 TSHR (0.73) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12607036 0.90 TSHR (0.79) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL2033933 0.90 TSHR (0.79) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL939180 0.90 TSHR (0.79) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL26002001 0.86 TSHR (0.78) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL26002003 0.86 TSHR (0.78) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL5973493 0.85 ATM (0.50) TSHRALDH1A1TP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004050-B1 CYANOSTILBENES ROLIC TECH AG (CH) 2020-09-02 EP disclosed
US-10329486-B2 Cyanostilbenes ROLIC AG (CH) 2019-06-25 US disclosed
US-20160083655-A1 CYANOSTILBENES ROLIC AG (CH) 2016-03-24 US disclosed
EP-1928979-A1 FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS Rolic AG (CH) 2008-06-11 EP disclosed
WO-2007033506-A1 FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS ROLIC AG (CH) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083655-A1 CYANOSTILBENES LATS1, LATS2, CRY1 TSHR 4718/4885ALDH1A1 2838/4885TP53 2241/4885
US-10329486-B2 Cyanostilbenes LATS1, LATS2, CRY1 TSHR 4718/4885ALDH1A1 2838/4885TP53 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.